ArticleDie Naturwissenschaften2025
Effects of neural stem cell-derived exosomes on MPTP-induced Parkinson's disease in mice.
Article in Die Naturwissenschaften, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Stem Cell-Derived Exosomes Regulate Mitochondrial Function: A Novel Strategy for Parkinson's Disease Therapy.Molecular neurobiology · 2026Review
- Stem cell extracellular vesicles for neuropsychiatric disorders and translation.Extracellular vesicles and circulating nucleic acids · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
Abstract
The objective of the study is to establish an extraction method of exosomes (Exos) from neural stem cells (NSCs) and to explore the effect of exosomes on 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine, MPTP). In this study, neural stem cell-derived exosomes (NSC-Exos) were extracted for treatment; a mouse model of PD induced by MPTP was established. After the treatment with NSC-Exos, the behavioral ability of mice in the EXO group was significantly improved compared to that in the MPTP group. The biochemical index test results showed that compared with that in the MPTP group, the activity of SOD and the content of GSH in the serum of mice in the EXO group increased (P < 0.01), while the content of MDA decreased (P < 0.05). Hematoxylin-eosin staining (HE) was used to observe the histopathological morphological changes in the brain of PD mice. Western blot results showed that compared with that in the MPTP group, after the treatment with NSC-Exos, the expression level of α-syn protein in the brain tissue of mice in the EXO group decreased, while that of TH protein increased (P < 0.05); compared with those in the MPTP group, the expression levels of I-κB, NF-κB, IL-6, IL-1β, and TNF-α proteins increased (P < 0.01). The 16S rDNA sequencing results of mouse gut microbiota showed that compared with that in the MPTP group, the abundance of Firmicutes decreased (P < 0.05), while the abundance of Bacteroidetes and Actinobacteria increased (P < 0.05) in the EXO group. The results of this study indicate that NSC-Exos have a certain therapeutic effect on the MPTP-induced PD in mice.
Indexed as
Identifiers
40699331What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.